Mesenchymal stem cells support hepatocyte function in engineered liver grafts.
Ontology highlight
ABSTRACT: Recent studies suggest that organ decellularization is a promising approach to facilitate the clinical application of regenerative therapy by providing a platform for organ engineering. This unique strategy uses native matrices to act as a reservoir for the functional cells which may show therapeutic potential when implanted into the body. Appropriate cell sources for artificial livers have been debated for some time. The desired cell type in artificial livers is primary hepatocytes, but in addition, other supportive cells may facilitate this stem cell technology. In this context, the use of mesenchymal stem cells (MSC) is an option meeting the criteria for therapeutic organ engineering. Ideally, supportive cells are required to (1) reduce the hepatic cell mass needed in an engineered live
SUBMITTER: Kadota Y
PROVIDER: S-EPMC4154962 | biostudies-literature | 2014 Apr-Jun
REPOSITORIES: biostudies-literature
ACCESS DATA